What is the Child-Pugh classification for liver disease?

Child-Pugh Classification for Liver Disease

The Child-Pugh classification is a scoring system that assesses liver disease severity, primarily in cirrhosis, using five clinical and laboratory variables to stratify patients into three classes (A, B, or C) with distinct prognostic implications.

Scoring System Components

The Child-Pugh score is calculated using five variables, each assigned 1-3 points 1, 2, 1:

Clinical Parameters:

• Hepatic encephalopathy: None (1 point), Grade 1-2 (2 points), Grade 3-4 (3 points)
• Ascites: Absent (1 point), Slight/mild (2 points), Moderate/tense (3 points)

Laboratory Parameters:

• Total bilirubin: <2 mg/dL (1 point), 2-3 mg/dL (2 points), >3 mg/dL (3 points)
• Serum albumin: >3.5 g/dL (1 point), 2.8-3.5 g/dL (2 points), <2.8 g/dL (3 points)
• INR (International Normalized Ratio): <1.7 (1 point), 1.7-2.2 (2 points), >2.2 (3 points)

Note: For primary biliary cirrhosis specifically, bilirubin scoring differs: 1-4 mg/dL (1 point), 4-10 mg/dL (2 points), >10 mg/dL (3 points) 3.

Classification and Prognosis

Child-Pugh Class A (5-6 points): Mild/compensated cirrhosis

• Represents good hepatic function
• 5-year survival approximately 90% 3
• Perioperative mortality 5-10% 4

Child-Pugh Class B (7-9 points): Moderate/decompensated cirrhosis

• Represents moderate hepatic dysfunction
• 5-year survival approximately 80% 3
• Perioperative mortality increases significantly

Child-Pugh Class C (10-15 points): Severe/decompensated cirrhosis

• Represents advanced hepatic dysfunction
• Median survival 1-2 years 5
• Perioperative mortality 30-50% 4
• One-year survival approximately 40% 6

Clinical Applications

Risk Stratification

The Child-Pugh classification serves multiple critical functions 2, 7:

• Surgical candidacy assessment: Class A patients are generally acceptable surgical candidates, while Class B/C patients have prohibitively high perioperative mortality 4
• Liver transplantation evaluation: Helps determine transplant timing and urgency 3
• Treatment allocation: Guides decisions for hepatocellular carcinoma therapy, variceal management, and systemic treatments 2, 7

Anticoagulation Management

Child-Pugh classification directly impacts anticoagulation decisions in patients with atrial fibrillation 1, 8:

• Class A: DOACs and warfarin can be used with caution
• Class B: Apixaban, dabigatran, and edoxaban reasonable; rivaroxaban contraindicated; warfarin should be avoided
• Class C: All DOACs and warfarin contraindicated due to bleeding risk

Antiviral Therapy in Hepatitis C

Treatment feasibility varies by class 9:

• Class A: Antiviral therapy indicated, particularly with hepatocellular carcinoma
• Class B: Consider treatment on individual basis in experienced centers only
• Class C: Current antiviral regimens contraindicated due to life-threatening complication risk

Advantages and Limitations

Strengths 2:

• Simple bedside calculation requiring readily available parameters
• Incorporates both objective laboratory values and clinical assessments
• Well-validated prognostic tool across multiple clinical scenarios
• Low cost and widely available

Limitations 7:

• Subjective components: Ascites assessment by imaging and encephalopathy grading introduce variability
• Temporary events not captured: Acute kidney injury, spontaneous bacterial peritonitis, hyponatremia, and malnutrition may indicate end-stage disease requiring transplant consideration but aren't directly scored
• INR variability: High inter-laboratory variation in INR measurement in cirrhotic patients reduces reliability 8
• Limited discrimination: Does not capture all prognostic nuances in compensated cirrhosis

Alternative Assessment Tools

While Child-Pugh remains the standard, complementary tools exist 2, 3:

• MELD score: Uses bilirubin, creatinine, and INR; particularly useful for transplant prioritization and predicting short-term mortality
• ALBI score: Albumin-bilirubin grade; more objective than Child-Pugh, useful for substratifying Class A patients
• HVPG (Hepatic Venous Pressure Gradient): Direct portal pressure measurement; defines clinically significant portal hypertension (≥10 mmHg)

Common Pitfalls

Avoid these errors when using Child-Pugh classification:

1. Applying to acute liver failure: Child-Pugh is designed for chronic liver disease/cirrhosis, not acute presentations
2. Ignoring clinical context: A patient may have compensated cirrhosis by score but have complications (refractory ascites, hepatorenal syndrome) indicating terminal disease 7
3. Using for non-cirrhotic liver disease: The classification specifically assesses cirrhosis severity
4. Overlooking portal hypertension signs: Esophageal varices, splenomegaly, and thrombocytopenia indicate clinically significant portal hypertension regardless of Child-Pugh class 2, 5

The Child-Pugh classification remains a cornerstone of cirrhosis assessment despite its limitations, providing essential prognostic information that guides critical clinical decisions from surgical candidacy to medication dosing 10, 6.